HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures.

AbstractOBJECTIVE:
To evaluate the perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgery.
SUMMARY BACKGROUND DATA:
Although COVID-19 infection is usually associated with mild disease, it can lead to severe respiratory complications. Little is known about the perioperative outcomes of patients with COVID-19.
METHODS:
We examined patients who underwent urgent and emergent surgery at 2 hospitals in New York City from March 17 to April 15, 2020. Elective surgical procedures were cancelled throughout and routine, laboratory based COVID-19 screening was instituted on April 1. Mortality, complications, and admission to the intensive care unit were compared between patients with COVID-19 detected perioperatively and controls.
RESULTS:
Among 468 subjects, 36 (7.7%) had confirmed COVID-19. Among those with COVID-19, 55.6% were detected preoperatively and 44.4% postoperatively. Before the routine preoperative COVID-19 laboratory screening, 7.7% of cases were diagnosed preoperatively compared to 65.2% after institution of screening (P = 0.0008). The perioperative mortality rate was 16.7% in those with COVID-19 compared to 1.4% in COVID-19 negative subjects [aRR = 9.29; 95% confidence interval (CI), 5.68-15.21]. Serious complications were identified in 58.3% of COVID-19 subjects versus 6.0% of controls (aRR = 7.02; 95%CI, 4.96-9.92). Cardiac arrest, sepsis/shock, respiratory failure, pneumonia, acute respiratory distress syndrome, and acute kidney injury were more common in those with COVID-19. The intensive care unit admission rate was 36.1% in those with COVID-19 compared to 16.4% of controls (aRR = 1.34; 95%CI, 0.86-2.09).
CONCLUSIONS:
COVID-19 is associated with an increased risk for serious perioperative morbidity and mortality. A substantial number of patients with COVID-19 are not identified until after surgery.
AuthorsAnne Knisely, Zhen Ni Zhou, Jenny Wu, Yongmei Huang, Kevin Holcomb, Alexander Melamed, Arnold P Advincula, Anil Lalwani, Fady Khoury-Collado, Ana I Tergas, Caryn M St Clair, June Y Hou, Dawn L Hershman, Mary E D'Alton, Yolanda Ya-Chin Huang, Jason D Wright
JournalAnnals of surgery (Ann Surg) Vol. 273 Issue 1 Pg. 34-40 (01 01 2021) ISSN: 1528-1140 [Electronic] United States
PMID33074900 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • COVID-19 (epidemiology)
  • Comorbidity
  • Female
  • Follow-Up Studies
  • Humans
  • Intensive Care Units (statistics & numerical data)
  • Male
  • Middle Aged
  • Morbidity (trends)
  • Postoperative Complications (epidemiology)
  • Retrospective Studies
  • SARS-CoV-2
  • Surgical Procedures, Operative (adverse effects)
  • Survival Rate (trends)
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: